Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
暂无分享,去创建一个
J. Silverberg | A. Pink | J. Gutermuth | S. Barbarot | S. Weidinger | S. Kalia | A. Chiricozzi | A. Pinter | M. Zirwas | D. N. Adam | T. Mark | Ann-Marie Tindberg